Navigation Links
PROTEAN II xi 2-D Cell from Bio-Rad

ProductsPROTEAN II xi 2-D Cell from Bio-Rad
Company Bio-Rad
Item PROTEAN II xi 2-D Cell
Price 
Description The PROTEAN II xi 2-D system runs both gel dimensions in the same cell. Up to 16 first-dimension IEF tube gels can be separated in a single run using the tube gel adaptors, which snap onto the cooling core in much the same manner as the slab gel assembly. While the tube gels are running, the second-dimension slab gels may be cast in the casting stand. The 20 cm long slab gel option provides extra gel length for optimal 2-D resolution. Beveled plates provided with the 2-D cell, and the accessibility of the slab gel surface, make it easy to position tube gels on the slab gel without an agarose overlay. With notched glass plates, up to 4 second-dimension slab gels can be run at a time. If more gels are required, the PROTEAN II xi multi-cell provides a 12 gel capacity while using identical cell components.

1.0 mm, 16 cm 165-1931
1.5 mm, 16 cm 165-1932
1.0 mm, 20 cm 165-1933
1.5 mm, 20 cm 165-1934

Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. PROTEAN Plus Overlay Agarose, 125 ml from Bio-Rad
2. PROTEAN II xi Cell, 20 cm, without spacers and combs from Bio-Rad
3. PROTEAN II xi Cell, 16 cm, without spacers and combs from Bio-Rad
4. PROTEAN II XL Cell, wide format from Bio-Rad
5. PROTEAN II xi Multi-Cell from Bio-Rad
6. PROTEAN II XL Cell, wide format, 2.0 mm from Bio-Rad
7. PROTEAN II xi Multi-Cell 2-D Conversion Kit from Bio-Rad
8. PROTEAN II xi Cell 2-D Conversion Kit. from Bio-Rad
9. Mini-PROTEAN II Multiscreen Apparatus from Bio-Rad
10. Mini-PROTEAN II Multiscreen Apparatus from Bio-Rad
11. PROTEAN II Slab Gel Casting Stand, with gaskets from Bio-Rad
(Date:8/21/2014)... the pancreas digesting itself resulting in severe abdominal pain, ... around 20,000 patients are diagnosed with the disease resulting ... treatment is restricted to intravenous fluid and nutritional support. ... Life Sciences, who led the research, said "The major ... stones and excessive alcohol intake combined with a high ...
(Date:8/20/2014)... , Aug. 20, 2014 /CNW/ -  Issue ... and can quickly become life threatening for some children.    ... as 1.2 million Canadians have food allergies and this number ... cent of children are estimated to have food allergies.  ... mild skin irritations and hives to breathing difficulties and loss ...
(Date:8/20/2014)... of Health has awarded the Oklahoma Medical Research Foundation ... on anthrax and the bacteria,s effects on humans. ... and his colleagues have studied the human immune response ... for Human Immunology. The original funding came soon after ... heels of the terrorist attacks of Sept. 11, 2001. ...
Breaking Biology News(10 mins):Insulin offers new hope for the treatment of acute pancreatitis 2Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3$14.5 million grant awarded to continue anthrax studies 2
... United States, African Americans have approximately twice the risk ... a similar prevalence in earlier stages of chronic kidney ... (GW) researcher Dominic Raj, M.D., identifies factors that mediate ... black patients and white patients, as well as among ...
... range-wide assessment of the bonobo (formerly known as the ... known and endangered great ape is quickly losing space ... of usable habitat is attributed to both forest fragmentation ... of Georgia, University of Maryland, the Wildlife Conservation Society, ...
... University School of Medicine (BUSM) and Boston Medical Center ... initiative funded by the Bill & Melinda Gates Foundation. ... BMC, and Ducksoo Kim, MD, professor of radiology at ... fellowship at BMC, will use nanotechnology to develop a ...
Cached Biology News:Genetics contribute to increased risk for end-stage renal disease for African Americans with CKD 2Study finds the forgotten ape threatened by human activity and forest loss 2Study finds the forgotten ape threatened by human activity and forest loss 3BUSM/BMC receives Grand Challenges Explorations grant to develop next generation condom 2BUSM/BMC receives Grand Challenges Explorations grant to develop next generation condom 3
(Date:8/21/2014)... -- China Cord Blood Corporation (NYSE: CO ) ... results for the first quarter of fiscal year 2015 ... the US.  The Company will host ... August 29, 2014 to discuss its financial performance and ... followed by a question and answer session.  Interested parties ...
(Date:8/21/2014)... Gallus BioPharmaceuticals , LLC, ... manufacturing organization (CMO) announced today that it has ... company focused on the development of innovative approaches ... anti-prostate specific membrane antigen (PSMA) monoclonal antibody used ... the agreement the antibody will be produced in ...
(Date:8/20/2014)... of patented university inventions licensed to biotechnology firms ... commercialization. To open these roadblocks, the researchers suggest ... the discovery stage could lead to faster commercialization ... derived from discoveries made in university laboratories and ... during clinical trials, which have a high failure ...
(Date:8/20/2014)... 2014 High performance computing (HPC) ... most complete climate and Earth system model to ... issues. , Eight national laboratories, including Lawrence ... Center for Atmospheric Research, four academic institutions and ... participating national laboratories include Argonne, Brookhaven, Lawrence Berkeley, ...
Breaking Biology Technology:China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3